Alunacedase alpha

Alunacedase alpha

«APN01» is the recombinant form of human angiotensin converting enzyme 2 (rhACE2) and mimics the natural form of ACE2, a receptor that is considered an essential cellular entry gateway for SARS-CoV-2virus into cell and plays a critical role in the treatment of COVID-19. The virus binds to the ACE2 on human cells by means of its SPIKE proteins in order to enter them. APN01, the soluble form of ACE2, can prevent the binding of the virus spike protein to the cell surface receptor and thus prevent the infection of cells.